Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram

Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

gedeon richter plc. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram

Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram

Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+20 mikrogram

Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram

Європейський Союз - данська - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - daclatasvir dihydrochlorid - hepatitis c kronisk - antivirale midler til systemisk anvendelse - daklinza er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c virus (hcv) infektion hos voksne (se afsnit 4. 2, 4. 4 og 5. for hcv-genotype specifik aktivitet, se afsnit 4. 4 og 5.

Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

bayer ab - drospirenon, ethinylestradiol - filmovertrukne tabletter - 3,0 mg+0,020 mg

Європейський Союз - данська - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - narkotika anvendt i diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 og 5.

Європейський Союз - данська - EMA (European Medicines Agency)

eli lilly nederland b.v. - dulaglutide - diabetes mellitus, type 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for undersøgelsens resultater med hensyn til kombinationer, effekt på glykæmisk kontrol og hjerte-kar-hændelser, og de befolkninger, der studerede, se afsnit 4. 4, 4. 5 og 5.

Данія - данська - Lægemiddelstyrelsen (Danish Medicines Agency)

gedeon richter plc. - desogestrel, ethinylestradiol - filmovertrukne tabletter - 150+20 mikrogram